Relapse is uncommon in patients with large B-cell lymphoma who are in complete remission at the end of fixed-course glofitamab treatment Meeting Abstract
| Authors: | Hutchings, M.; Carlo-Stella, C.; Morschhauser, F.; Bachy, E.; Corradini, P.; Iacoboni, G.; Khan, C.; Patel, K.; Hertzberg, M.; Falchi, L.; Bartlett, N. L.; Brody, J.; Lundberg, L.; Xie, Y.; Mulvihill, E.; Baumlin, P.; Relf, J.; Piccione, E.; Humphrey, K.; Dickinson, M. |
| Abstract Title: | Relapse is uncommon in patients with large B-cell lymphoma who are in complete remission at the end of fixed-course glofitamab treatment |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 1062 |
| End Page: | 1064 |
| Language: | English |
| ACCESSION: | WOS:000893223201027 |
| DOI: | 10.1182/blood-2022-157554 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
